Paula R. Clemens

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

K. Bushby, Richard S. Finkel, David J. Birnkrant et al. · The Lancet Neurology · 2009 · 2K citations

Part 1, Kinesiology, Psychiatry +9

A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease

Ans T. van der Ploeg, Paula R. Clemens, Deyanira Corzo et al. · New England Journal of Medicine · 2010 · 726 citations · Full text

A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.

Stefan Kochanek, Paula R. Clemens, K Mitani et al. · Proceedings of the National Academy of Sciences · 1996 · 566 citations · Full text

Viral Replication, Immunology, Pathology +17

Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study

Craig M. McDonald, Erik Henricson, Richard T. Abresch et al. · The Lancet · 2017 · 446 citations

Long-term Effects, Duchenne Muscular Dystrophy, Degenerative Disease +4

NF-κB inhibition delays DNA damage–induced senescence and aging in mice

Jeremy S. Tilstra, Andria R. Robinson, Jin Wang et al. · Journal of Clinical Investigation · 2012 · 433 citations